secwatch.observer — SEC 8-K summary
======================================

Issuer:     Target Group Inc. (CBDY)
CIK:        0001586554
Form:       8-K
Filed at:   2022-05-09T23:59:59+00:00
Accession:  0001104659-22-057577
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Target Group subsidiary receives CDN$2.04M payout from Thrive, JV continues
---------------------------------------------------------------------------

- CanaryRx (Target Group subsidiary) received CDN$2,043,082.74 from Thrive to fully repay JV indebtedness.
- Thrive paid the amount on May 6, 2022, satisfying all Outstanding JV and Product Obligations.
- The Joint Venture Operations Agreement between CanaryRx, Thrive, and JVCo remains in full force.
- The payout covers start-up hard costs ($921,581.48) and excess costs ($1,121,501.26).
- The agreement facilitates Thrive's parent Terrafarma's planned amalgamation with Aurora Cannabis Inc.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1586554/000110465922057577/0001104659-22-057577-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1586554/000110465922057577/tm2214947d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-057577

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer